{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T11:10:59Z","timestamp":1790939459451,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2394,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuron"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.neuron.2007.01.022","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T19:45:54Z","timestamp":1176925554000},"page":"577-589","source":"Crossref","is-referenced-by-count":61,"title":["Disruption of the CRF\/CRF1 Receptor Stress System Exacerbates the Somatic Signs of Opiate Withdrawal"],"prefix":"10.1016","volume":"53","author":[{"given":"Francesco","family":"Papaleo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Kitchener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Contarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuron.2007.01.022_bib1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0006-8993(92)90654-R","article-title":"Hypothalamic corticotropin-releasing hormone and opioid peptide neurons: functional changes after adrenalectomy and\/or castration","volume":"571","author":"Almeida","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1146\/annurev.pharmtox.44.101802.121410","article-title":"CRF and CRF receptors: role in stress responsivity and other behaviors","volume":"44","author":"Bale","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuron.2007.01.022_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s002130050983","article-title":"Heroin self-administration in dependent Wistar rats: increased sensitivity to naloxone","volume":"144","author":"Carrera","year":"1999","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1054\/npep.2002.0899","article-title":"Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior","volume":"36","author":"Contarino","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuron.2007.01.022_bib5","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1073\/pnas.0506999102","article-title":"The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal","volume":"102","author":"Contarino","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2007.01.022_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)01158-5","article-title":"Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1","volume":"835","author":"Contarino","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1210\/endo.140.1.6415","article-title":"The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress","volume":"140","author":"Deak","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuron.2007.01.022_bib9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0376-8716(85)90014-6","article-title":"Hypothalamus-pituitary-adrenal axis of heroin addicts","volume":"15","author":"Facchinetti","year":"1985","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuron.2007.01.022_bib10","series-title":"Handbook of Chemical Neuroanatomy","first-page":"1","article-title":"Neuropeptides in the CNS, part II","author":"Fallon","year":"1990"},{"key":"10.1016\/j.neuron.2007.01.022_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1254\/jjp.82.175","article-title":"Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal","volume":"82","author":"Fukunaga","year":"2000","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuron.2007.01.022_bib12","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1460-9568.1999.00462.x","article-title":"Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum","volume":"11","author":"Georges","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1124\/pr.55.1.3","article-title":"International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands","volume":"55","author":"Hauger","year":"2003","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuron.2007.01.022_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.npp.1380104","article-title":"Anti-stress action of a corticotropin-releasing factor antagonist on behavioral reactivity to stressors of varying type and intensity","volume":"11","author":"Heinrichs","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2007.01.022_bib15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00008877-199501000-00011","article-title":"Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal","volume":"6","author":"Heinrichs","year":"1995","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuron.2007.01.022_bib16","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1523\/JNEUROSCI.1641-04.2004","article-title":"Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment","volume":"24","author":"Houshyar","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1471-4159.2000.0740199.x","article-title":"Role of corticotropin-releasing factor receptor-1 in opiate withdrawal","volume":"74","author":"Iredale","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2007.01.022_bib18","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0306-4522(94)00537-F","article-title":"Acute and chronic amphetamine treatments differently regulate neuropeptide messenger RNA levels and Fos immunoreactivity in rat striatal neurons","volume":"65","author":"Jaber","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2007.01.022_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00213-005-2164-z","article-title":"The effects of CRF antagonists, antalarmin, CP154,526, LWH234, and R121919, in the forced swim test and on swim-induced increases in adrenocorticotropin in rats","volume":"180","author":"Jutkiewicz","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib20","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.1523\/JNEUROSCI.0740-06.2006","article-title":"Conditioned withdrawal drives heroin consumption and decreases reward sensitivity","volume":"26","author":"Kenny","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0006-8993(99)01991-5","article-title":"A role for corticotropin releasing factor and urocortin in behavioral responses to stressors","volume":"848","author":"Koob","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","article-title":"Drug addiction, dysregulation of reward, and allostasis","volume":"24","author":"Koob","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2007.01.022_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(98)00064-7","article-title":"Drug dependence: stress and dysregulation of brain reward pathways","volume":"51","author":"Kreek","year":"1998","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuron.2007.01.022_bib24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1113\/jphysiol.1988.sp017261","article-title":"Corticotrophin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat","volume":"403","author":"Lightman","year":"1988","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuron.2007.01.022_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00426773","article-title":"Naloxone-precipitated withdrawal as a function of the morphine-naloxone interval","volume":"54","author":"Linseman","year":"1977","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib26","first-page":"4398","article-title":"Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence","volume":"12","author":"Lu","year":"2000","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib27","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00213-005-2207-5","article-title":"Role of withdrawal in reinstatement of morphine-conditioned place preference","volume":"181","author":"Lu","year":"2005","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib28","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1471-4159.1998.71020833.x","article-title":"Effects of adrenal steroids on basal ganglia neuropeptide mRNA and tyrosine hydroxylase radioimmunoreactive levels in the adrenalectomized rat","volume":"71","author":"Lucas","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2007.01.022_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.molbrainres.2004.05.014","article-title":"DeltaFosB: a molecular switch for long-term adaptation in the brain","volume":"132","author":"McClung","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib30","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0006-8993(87)90088-6","article-title":"Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A\u00a0place conditioning study in the rat","volume":"418","author":"Mucha","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1124\/jpet.105.083410","article-title":"D1 dopamine receptors modulate deltaFosB induction in rat striatum after intermittent morphine administration","volume":"314","author":"Muller","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuron.2007.01.022_bib33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0024-3205(92)90077-3","article-title":"Stress-induced changes in brain Met-enkephalin, Leu-enkephalin and dynorphin concentrations","volume":"51","author":"Nabeshima","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.neuron.2007.01.022_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/35053570","article-title":"Molecular basis of long-term plasticity underlying addiction","volume":"2","author":"Nestler","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib35","unstructured":"NIDA (National Institute on Drug Abuse). (2005). Monitoring the future:\u00a0national results on adolescent drug use (http:\/\/www.monitoringthefuture.org)."},{"key":"10.1016\/j.neuron.2007.01.022_bib36","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"557","article-title":"Drug addiction and drug abuse","author":"O'Brien","year":"1996"},{"key":"10.1016\/j.neuron.2007.01.022_bib37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbr.2006.02.009","article-title":"Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice","volume":"170","author":"Papaleo","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib38","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuron.2007.01.022_bib39","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-8993(92)90896-H","article-title":"The effect of morphine tolerance dependence and abstinence on immunoreactive dynorphin (1-13) levels in discrete brain regions, spinal cord, pituitary gland and peripheral tissues of the rat","volume":"584","author":"Rattan","year":"1992","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib40","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1460-9568.2005.04197.x","article-title":"Hypothalamic projections to locus coeruleus neurons in rat brain","volume":"22","author":"Reyes","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/305325a0","article-title":"Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin","volume":"305","author":"Rivier","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.neuron.2007.01.022_bib42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0006-8993(95)00043-P","article-title":"Brain corticotropin-releasing factor mediates \u2018anxiety-like\u2019 behavior induced by cocaine withdrawal in rats","volume":"675","author":"Sarnyai","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib43","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1523\/JNEUROSCI.07-04-01093.1987","article-title":"Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity","volume":"7","author":"Sawchenko","year":"1987","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib44","first-page":"5","article-title":"The functional neuroanatomy of corticotropin-releasing factor","volume":"172","author":"Sawchenko","year":"1993","journal-title":"Ciba Found. Symp."},{"key":"10.1016\/j.neuron.2007.01.022_bib45","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/BF02532385","article-title":"Reinforcement processes in opiate addiction: a homeostatic model","volume":"21","author":"Schulteis","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib46","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s002130050608","article-title":"CP-154,526, a selective, nonpeptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats","volume":"137","author":"Shaham","year":"1998","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuron.2007.01.022_bib48","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","article-title":"Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects","volume":"90","author":"Shirayama","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuron.2007.01.022_bib49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0896-6273(00)80491-2","article-title":"Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development","volume":"20","author":"Smith","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.neuron.2007.01.022_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.npp.1300487","article-title":"Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats","volume":"30","author":"Stinus","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuron.2007.01.022_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(93)90055-R","article-title":"Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats","volume":"624","author":"Stornetta","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib52","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1210\/endo.139.9.6192","article-title":"Corticosterone can facilitate as well as inhibit corticotropin-releasing hormone gene expression in the rat hypothalamic paraventricular nucleus","volume":"139","author":"Tanimura","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuron.2007.01.022_bib53","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/520","article-title":"Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1","volume":"19","author":"Timpl","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuron.2007.01.022_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(96)00363-6","article-title":"Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration","volume":"76","author":"Tjon","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuron.2007.01.022_bib55","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1530-0277.2002.tb02448.x","article-title":"Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor","volume":"26","author":"Valdez","year":"2002","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.neuron.2007.01.022_bib56","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1073\/pnas.0402208101","article-title":"Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability","volume":"101","author":"Wei","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neuron.2007.01.022_bib57","doi-asserted-by":"crossref","first-page":"L53","DOI":"10.1016\/S0024-3205(99)00268-4","article-title":"Chronic administration of the nonpeptide CRH type 1 receptor antagonist antalarmin does not blunt hypothalamic-pituitary-adrenal axis responses to acute immobilization stress","volume":"65","author":"Wong","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.neuron.2007.01.022_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nn1636","article-title":"An essential role for DeltaFosB in the nucleus accumbens in morphine action","volume":"9","author":"Zachariou","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuron.2007.01.022_bib59","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0006-8993(02)03189-X","article-title":"Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat","volume":"952","author":"Zorrilla","year":"2002","journal-title":"Brain Res."}],"container-title":["Neuron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627307000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896627307000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:22:34Z","timestamp":1556364154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896627307000633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0896627307000633"],"URL":"https:\/\/doi.org\/10.1016\/j.neuron.2007.01.022","relation":{},"ISSN":["0896-6273"],"issn-type":[{"value":"0896-6273","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}